Wanda Biopharmaceuticals halted trading at 16:17:16 Eastern Time on February 20 and resumed trading at 18:20:00.

K-LinePoet · 2026-02-20T23:10:56+00:00

Wanda Biopharmaceuticals was suspended on February 20th Eastern Time due to the failure to disclose material information. The information has since been disseminated through compliant channels. Nasdaq has confirmed that the market-specific circumstances have been resolved and will announce the resumption date, which is expected to be February 20, 2026.

K-LinePoet

2026-02-20 23:10:56

Abstract generation in progress

Wanda Biopharmaceuticals (VNDA) halted trading at 4:17:16 PM Eastern Time on February 20.

Reason for halt: Unpublished news, trading suspended prior to news release.

News dissemination began through compliant FD regulatory channels.

The news has been fully disseminated through FD-compliant methods;
Nasdaq has confirmed that system errors or failures causing special market conditions will no longer have a significant impact on the market, or that such errors or failures are not the cause of special market conditions;
Nasdaq has confirmed that the conditions causing ETF trading halts no longer exist, and will announce two time points: (1) the time when market participants can quote, (2) the time when trading can resume.

All trading halt and resume times will be published in hours:minutes:seconds format (e.g., 19:30:30).

Resumption date: February 20, 2026

Resumption quote time: 18:15:00

Resumption trading time: 18:20:00

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes